Scientists at a Chinese university have developed a 3-D-printable protein that can withstand extreme temperatures and temperatures far beyond what is safe for humans to handle.
The team, led by Professor Zhao Xuezhuang, from Zhejiang University in China, has published its work on its breakthrough protein, which was named as Cry1Ab.
“The new Cry1AB is a perfect material for the next generation of 3D printing, with a great potential for its use in biopharmaceutical manufacturing,” Zhao told AP.
Cry1Ab is a new protein developed by the Zhe-hua Institute of Nanotechnology and Biotechnology and is a key player in a new generation of biotechnology based on 3D bioprinting.
It is a synthetic protein derived from the bacterial DNA strand that was synthesized using DNA-to-RNA fusion.
Its unique properties include a high-temperature stability, and it can withstand up to 100 degrees Celsius.
The protein is produced in the lab and then fused with a synthetic scaffold that includes the DNA strand.
It can then be printed at high temperatures to create an artificial cell.
It’s a unique and promising technology that’s gaining increasing attention because of its ability to withstand extreme conditions.
The new technology is similar to 3D printed plastic, or plastic-based bioengineered tissue, which is currently being used for biomedical testing.
It was not immediately clear how the protein was made, but the Zhaoxing research team noted that it could be made using a wide variety of materials.
“For example, we can also use it to create new biocompatible materials that will benefit in the future,” the team wrote in a press release.
“We have already made 3D copies of several proteins, which are used in many medical devices.
These new proteins are able to withstand very high temperatures and extreme conditions.”
Zhao’s team has been working on a new 3-dimensional protein that could help in the manufacture of biocontrol products, which would allow doctors to better treat cancer patients.
Cry2Ab, another new protein made by Zhaozing, has been used to treat a rare type of cancer called non-small cell lung cancer.
It was recently developed by researchers from Shanghai Institute of Technology and the National Institute of Biotechnology.
Cry3Ab, a synthetic version of Cry1ab, is being used to make novel therapies for cancer.
Its development is being led by scientists at the University of Washington in Seattle and the University at Albany.
Cry4Ab, an engineered protein made from a DNA strand from a bacterium, is currently undergoing clinical trials to treat multiple types of cancer.
The new proteins could also be used to manufacture the scaffold for 3D printers that can be used for medical implants.
Zhao told AP that it would take a long time for the Cry1 and Cry2 proteins to be used in 3-d printers.
“In terms of the commercialization, we will first have to prove that the materials can withstand very hot and extremely cold environments, and that they can withstand different types of chemical reactions,” he said.
“Then, we would have to develop a new method to make the scaffolds and assemble the 3D printer.
It would take several years for these materials to be commercialized.”